Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.002 |
mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.003 |
mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.098 | 0.003 |
mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.003 |
mRNA | ML006 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |